Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nik Ding

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Gastroenterology & Hepatology|May 27, 2020
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international surveyWebber Chan, Viraj C Kariyawasam, Shin Kim, et al.
Internal Medicine Journal|September 16, 2022
Clinical outcomes amongst elderly patients with inflammatory bowel diseaseVithoosharan Sivanathan, Chamara Basnayake, William Connell, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2020
The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 SurveyGabriele Dragoni, Nik Ding, Krisztina B Gecse, et al.
Intestinal Research|December 22, 2024
Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyRobert Gilmore, Richard Fernandes, Imogen Hartley, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trialEdouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Hepatology Communications|May 2, 2024
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisNatassia Tan, Natalie Ngu, Thomas Worland, et al.
Insights Into Imaging|March 19, 2025
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's diseaseNaomi S Sakai, Andrew A Plumb, Norin Ahmed, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Gastroenterology & Hepatology|May 27, 2020
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international surveyWebber Chan, Viraj C Kariyawasam, Shin Kim, et al.
Internal Medicine Journal|September 16, 2022
Clinical outcomes amongst elderly patients with inflammatory bowel diseaseVithoosharan Sivanathan, Chamara Basnayake, William Connell, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2020
The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 SurveyGabriele Dragoni, Nik Ding, Krisztina B Gecse, et al.
Intestinal Research|December 22, 2024
Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyRobert Gilmore, Richard Fernandes, Imogen Hartley, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trialEdouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Hepatology Communications|May 2, 2024
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisNatassia Tan, Natalie Ngu, Thomas Worland, et al.
Insights Into Imaging|March 19, 2025
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's diseaseNaomi S Sakai, Andrew A Plumb, Norin Ahmed, et al.
Pageof 2